Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

CeMM Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
University of Edinburgh Featured PhD Programmes
Imperial College London Featured PhD Programmes
Birkbeck, University of London Featured PhD Programmes
"leukemia"×
10 miles

leukemia PhD Projects, Programs & Scholarships

We have 7 leukemia PhD Projects, Programs & Scholarships

  • "leukemia" ×
  • clear all
Order by 
Showing 1 to 7 of 7
  Hematopoietic Stem Cell Genetics: Using single cell biology and genetics to understand how hematopoietic stem cells normally sustain blood formation, and how this process is altered during ageing and when leukemia develops.
  Prof Claus Nerlov, Dr P Vyas
Application Deadline: 11 January 2019
Using single cell biology and genetics to understand how hematopoietic stem cells normally sustain blood formation, and how this process is altered during ageing and when leukemia develops.
  ChromDesign-ITN: An epigenomic approach to study resistance and recurrence in acute myeloid leukemia (subproject ESR12); Hosting institution: IEO — European Institute of Oncology, Milan, Italy
  Prof Saverio Minucci, Prof Genevieve Almouzni
Application Deadline: 21 December 2018
"ChromDesign” is a European innovative and interdisciplinary Research and Training network, which aims to characterize the impact of the 3D chromatin organization on gene regulation during cellular differentiation and in several human disorders, and to train junior researchers in the biomedical field, either in academia or in the private sector.
  ChromDesign-ITN: Chromatin topology studies in mouse ES and human leukemia cell lines (subproject ESR13); Hosting institution: Diagnose, Liege, Belgium
  Dr Celine Sabatel, Prof MariaElena orres-Padilla
Application Deadline: 21 December 2018
"ChromDesign” is a European innovative and interdisciplinary Research and Training network, which aims to characterize the impact of the 3D chromatin organization on gene regulation during cellular differentiation and in several human disorders, and to train junior researchers in the biomedical field, either in academia or in the private sector.
  How is fate determined during T cell development, leukemogenesis and responses?
  Dr S. Russell
Applications accepted all year round
Understanding how cell fate programming works will lead to improved diagnostic and therapeutic opportunities for leukemia, and to improved immunotherapies for cancer and infectious disease.
  Therapeutic resolution of Myodysplastic Syndrome (MDS)
  Research Group: Pharmacology and Experimental Therapeutics
  Dr T Nasim, Dr K Pors
Applications accepted all year round
Myelodysplastic syndromes (MDS) are the most common adult myeloid malignancy in the UK and it has been estimated that around 8,000 and 40,000 new cases are diagnosed each year in the UK and USA, respectively.
  4 Year Wellcome Trust PhD Programme: Dissecting the epigenetic regulation of enhancer function in hematopoiesis
  Dr K Rasmussen
Application Deadline: 14 December 2018
The epigenetic mark of DNA methylation is established by DNMT (DNA methyltransferase) enzymes and has been shown to correlate with transcriptional states and influence cell identity and tumorigenesis in mammalian cells.
  MRC DTP 4 Year PhD Programme: Dissecting the epigenetic regulation of enhancer function in hematopoiesis
  Dr K Rasmussen, Dr G Schweikert
Application Deadline: 18 January 2019
This project is part of our exciting and challenging University of Dundee 4-year MRC DTP Programme in Quantitative and Interdisciplinary approaches to biomedical science.
Show 10 15 30 per page
  • 1


FindAPhD. Copyright 2005-2018
All rights reserved.